Related Experiment Videos

[Update in drug therapy in neuropediatry]

P Leroy1, J M Dubru, J P Misson

  • 1Service de Neuropédiatrie, CHR Citadelle, CHU Sart-Tilman, Liège, Belgique.

Revue Medicale De Liege
|August 30, 2007
PubMed

Insights

Newer antiepileptic drugs like lamotrigine and levetiracetam are effective for childhood seizures but have restricted reimbursement in Belgium. Atomoxetine offers a new treatment option for attention deficit hyperactivity disorder (ADHD) beyond methylphenidate.

Area of Science:

  • Pediatric Neurology
  • Pharmacology

Context:

  • Recent advancements in pediatric pharmacotherapy.
  • Limited access to antiepileptic drugs (AEDs) in Belgium.
  • Evolving treatment landscape for attention deficit hyperactivity disorder (ADHD).

Purpose:

  • To review the efficacy and accessibility of recent AEDs in children.
  • To introduce atomoxetine as an alternative ADHD treatment.
  • To highlight Belgian reimbursement policies for pediatric medications.

Summary:

  • Lamotrigine, topiramate, oxcarbazepine, and levetiracetam are recent AEDs with proven efficacy for various seizure types in children.
  • Reimbursement for these AEDs in Belgium is conditional, impacting treatment accessibility.
  • Atomoxetine presents a novel therapeutic option for pediatric ADHD, distinct from traditional methylphenidate treatment.

Impact:

  • Informs clinical practice regarding AED selection and access in Belgium.
  • Expands treatment options for children with ADHD.
  • Highlights the importance of medication accessibility and reimbursement policies in pediatric care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...